Profile
HCWB VRTX ALNY REGN ARGX SGEN
Company Name HCW Biologics Inc. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $9.08M $100.41B $61.64B $58.82B $48.74B $43.15B
Employees 0.04K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Hing C. Wong Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
HCWB VRTX ALNY REGN ARGX SGEN
Quant Rating Score 2 3 1 4 3 3
Quant Rating Sell Neutral Strong Sell Buy Neutral Neutral
Trading
HCWB VRTX ALNY REGN ARGX SGEN
Last Close $4.34 $407.9 $470.27 $576.42 $815.61 $228.74
High 52 $10.05 $516.74 $482.13 $998.23 $815.61 $228.74
Low 52 $0.21 $366.54 $224.58 $482.92 $532.27 $228.74
Price vs. 52 Week High -56.82 % -21.06 % -2.46 % -42.26 % 0 % 0 %
Price vs. 52 Week Low 1966.67 % 11.28 % 109.4 % 19.36 % 53.23 % 0 %
Total Return
HCWB VRTX ALNY REGN ARGX SGEN
1 Month Return 4.58 % 4.23 % 2.01 % 0.26 % 8.41 % 0 %
3 Month Return -9.39 % -13.13 % 45.68 % 5.31 % 41.3 % 0 %
6 Month Return -43.12 % -16.05 % 104.02 % 4.94 % 38.81 % 0 %
9 Month Return 1110.94 % -2.17 % 88.74 % -16.85 % 23.61 % 0 %
YTD Return 872.88 % 1.29 % 99.85 % -19.08 % 32.62 % 0 %
1 Year Return 675 % -18.21 % 58.47 % -42.26 % 49.97 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
HCWB VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) -83.45 % 11.09 % -0.43 % 4.37 % 65.28 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Growth
HCWB VRTX ALNY REGN ARGX SGEN
Asset Growth 6.04 % -0.87 %
Gross Profit Growth 71.21 % 10.25 %
Revenue Growth -9.68 % 11.66 %
Revenue 3 Year - 45.6 %
Revenue 5 Year - 163.93 %
Revenue 10 Year - 1632.15 %
EBIT Growth -16.81 % -93.69 %
Net Income Growth -20.12 % -114.8 %
Net Income 3 Yeari Growth Per Share -124.02 % -122.89 %
Net Income 5 Yeari Growth Per Share -293.38 % -145.38 %
Net Income 10 Yeari Growth Per Share -293.38 % 33.84 %
Operating Income Growth -14.63 % -106.08 %
Operating Cash Flow Growth (CFG) 36.81 % -113.93 %
Operating 3 Year CFG -19.52 % -118.65 %
Operating 5 Year CFG -98.96 % -131.3 %
Operating 10 Year CFG -98.96 % 12.43 %
EPS Growth -10 % -114.8 %
EPS Diluted Growth -10 % -114.97 %
Book Value Per Share -146.58 % -6.59 %
Share Holder 3 Year Equity Growth Per Share -112.19 % 62.6 %
Share Holder 5 Year Equity Growth Per Share -171.17 % 168.85 %
Share Holder 10 Year Equity Growth Per Share -171.17 % 1292.6 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth 117.19 % 116.42 %
Free Cash Flow Growth 49.54 % -124.1 %
Updated On 31 Dec 2024 31 Dec 2024
Profitability
HCWB VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM -61.95 % 86.11 % 83.64 % 81.98 % 65.82 % 79.1 %
Return on Assets TTM -74.56 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM 340.05 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -595.09 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 100 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 175.52 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM -1474.45 % 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -195.56 % 251.83 % -1.2 % 175.35 % 932.29 % -1043.73 %
Receivables Turnover TTM 38.54 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 0.07 3.59 3.93 3.54 0.9 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.26 0.96
Fixed Asset Turnover TTM 3.68 % 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM 2.88 % 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -7.05 14.98 -0.12 45.13 5.67 -2.46
Free Cash Flow Per Share TTM -7.14 13.63 -0.4 36.58 5.58 -2.88
Cash Per Share TTM 137.01 % 2486.48 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM -1507.79 % 33.68 % -0.63 % 33.37 % 17.54 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.2 % 90.99 % 335.21 % 81.05 % 98.47 % 117.04 %
Cash Flow Coverage Ratios TTM -195.56 % 251.83 % -1.2 % 175.35 % 932.29 % -1043.73 %
Price To Free Cash Flows Ratio TTM -0.71 28.69 -1183.43 15.3 123.13 -81.26
Price To Operating Cash Flows Ratio TTM -0.6 26.14 -3924.5 12.51 140.63 -93.1
Price Cash Flow Ratio TTM -0.6 26.14 -3924.5 12.51 140.63 -93.1
Income Statement (TTM)
HCWB VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 37.38% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.03B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.03B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -0.77 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
HCWB VRTX ALNY REGN ARGX SGEN
Long Term Debt $0.01B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.04B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $-0.01B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0.01B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.03B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
HCWB VRTX ALNY REGN ARGX SGEN
Net Income $-0.03B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $-0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 36.92
AARD Aardvark Therapeutics, Inc. Common Stock 13.29
ABCL AbCellera Biologics Inc. 5.835
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.4383
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.13
ABPWW 0.0325
ABSI Absci Corporation 4.8682
ABUS Arbutus Biopharma Corporation 4.51
ABVC ABVC BioPharma, Inc. 2.9
ABVX Abivax SA American Depositary Shares 92.52
ACAD ACADIA Pharmaceuticals Inc. 20.575
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 1.0235
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.07
ACIU AC Immune SA 2.99
ETFs With Exposure to HCWB
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 325.65
VXF Vanguard Extended Market Index Fund 0.00003 209.1
IWC iShares Micro-Cap ETF 0.00048 155.3
VTSAX Vanguard Total Stock Market Index Fund 0 159.79
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00003 161.24
VITSX Vanguard Total Stock Market Index Fund 0 159.82
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00003 161.25
VEMPX Vanguard Extended Market Index InstlPlus 0.00003 397.91
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 299.8
Unlock